pd 173074 has been researched along with Carcinoma, Epidermoid in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arsenic trioxide (ATO) was previously shown to suppress growth of lung cancer." | 1.43 | Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma. ( Ho, JC; Lam, SK; Leung, LL; Li, YY; Zheng, CY, 2016) |
| "Head and neck squamous cell carcinoma (HNSCC) is a complex disease process involving interactions with carcinoma-associated fibroblasts and endothelial cells." | 1.38 | Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor. ( Hart, J; Hartman, YE; Lancaster, W; Liu, Z; Rosenthal, EL; Sweeny, L, 2012) |
| "Head and neck squamous cell carcinoma tumors (HNSCC) contain a dense fibrous stroma which is known to promote tumor growth, although the mechanism of stroma-mediated growth remains unclear." | 1.37 | Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. ( Hartman, YE; Knowles, JA; Liu, Z; Rosenthal, EL; Sweeny, L; Warram, JM; Zhou, T, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nguyen, PT | 1 |
| Tsunematsu, T | 1 |
| Yanagisawa, S | 1 |
| Kudo, Y | 1 |
| Miyauchi, M | 1 |
| Kamata, N | 1 |
| Takata, T | 1 |
| Gyanchandani, R | 1 |
| Ortega Alves, MV | 1 |
| Myers, JN | 1 |
| Kim, S | 1 |
| Saito, S | 1 |
| Morishima, K | 1 |
| Ui, T | 1 |
| Hoshino, H | 1 |
| Matsubara, D | 1 |
| Ishikawa, S | 1 |
| Aburatani, H | 1 |
| Fukayama, M | 1 |
| Hosoya, Y | 1 |
| Sata, N | 1 |
| Lefor, AK | 1 |
| Yasuda, Y | 1 |
| Niki, T | 1 |
| Kotani, H | 1 |
| Ebi, H | 1 |
| Kitai, H | 1 |
| Nanjo, S | 1 |
| Kita, K | 1 |
| Huynh, TG | 1 |
| Ooi, A | 1 |
| Faber, AC | 1 |
| Mino-Kenudson, M | 1 |
| Yano, S | 1 |
| Lam, SK | 1 |
| Leung, LL | 1 |
| Li, YY | 1 |
| Zheng, CY | 1 |
| Ho, JC | 1 |
| Uzawa, K | 1 |
| Ishigami, T | 1 |
| Fushimi, K | 1 |
| Kawata, T | 1 |
| Shinozuka, K | 1 |
| Kasamatsu, A | 1 |
| Sakamoto, Y | 1 |
| Ogawara, K | 1 |
| Shiiba, M | 1 |
| Bukawa, H | 1 |
| Ito, H | 1 |
| Tanzawa, H | 1 |
| Liu, Z | 2 |
| Hartman, YE | 2 |
| Warram, JM | 1 |
| Knowles, JA | 1 |
| Sweeny, L | 2 |
| Zhou, T | 1 |
| Rosenthal, EL | 2 |
| Lancaster, W | 1 |
| Hart, J | 1 |
| Veach, DR | 1 |
| Namavari, M | 1 |
| Beresten, T | 1 |
| Balatoni, J | 1 |
| Minchenko, M | 1 |
| Djaballah, H | 1 |
| Finn, RD | 1 |
| Clarkson, B | 1 |
| Gelovani, JG | 1 |
| Bornmann, WG | 1 |
| Larson, SM | 1 |
9 other studies available for pd 173074 and Carcinoma, Epidermoid
| Article | Year |
|---|---|
The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1.
Topics: Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Cell Nucleus; Epithelial-Mesenchy | 2013 |
A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Squamou | 2013 |
The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cells, Cult | 2015 |
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Gene Ampli | 2016 |
Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell L | 2016 |
Targeting fibroblast growth factor receptor 3 enhances radiosensitivity in human squamous cancer cells.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Mice; Mice, Nude; Pyrimidines; Radiatio | 2011 |
Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.
Topics: Animals; Basigin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Female; Fibroblast | 2011 |
Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.
Topics: Animals; Carcinoma, Squamous Cell; Cell Proliferation; Fibroblasts; Head and Neck Neoplasms; Humans; | 2012 |
Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fusion | 2005 |